Dr Grace Wangge is a medical doctor and epidemiologist, teaching in the field of Public Health and Public Health Policy. She got her medical degree from Universitas Indonesia, Indonesia and PhD from Utrecht Universiteit in the Netherlands in the field of Pharmacoepidemiology. She also had a postdoctoral fellowship with Harvard Medical School/Brigham and Women’s Hospital, Boston, USA.
Since returning to Indonesia in 2014, she has developed research expertise in community medicine, community nutrition, public health policy and pharmacovigilance. She also has years of experience in research and capacity building at the grassroots level, as well as evaluating the implementation of health and nutrition programs in primary health services in Indonesia.
Priya Bahri, PhD, FISoP is the lead for Pharmacovigilance and Risk Management Guidance and Policies at the European Medicines Agency (EMA). In her role at EMA, she is also the editor of the EU good pharmacovigilance practice guidelines (EU-GVP), and she currently focusses on new approaches for stakeholder engagement to support regulatory decision-making and implementation of risk minimisation measures in healthcare. She has wide experience in the coordination of the European Union regulatory pharmacovigilance network, stakeholder interactions, and international collaboration at the level of WHO, CIOMS and the International Council of Harmonisation (ICH).
Before joining EMA in 1996, she had gained work experience in hospital and community pharmacies as well as in projects for associations of physicians in the public insurance system and for the German international development agency GTZ. Her background consists of a degree in pharmacy (University of Heidelberg), a post-graduate diploma in epidemiology & biostatistics (McGill University), and a PhD (Humboldt University Berlin with research at University Utrecht) on quality management for patient safety. She holds further post-graduate certificates in strategic health communication (Johns Hopkins University) and global health diplomacy (Graduate Institute Geneva).
As pro bono activities, she was lecturer for the previous master study programme Consumer Health Care at Humboldt University Berlin and now provides advice and lectures to the Utrecht Centre for Pharmaceutical Policy and Regulation as affiliated researcher. She was awarded as Fellow of the International Society of Pharmacovigilance (ISoP) and is also active in the International Society of Pharmacoepidemiology (ISPE). She is the editor of the book “Communicating about Risks and Safe Use of Medicines: Real Life and Applied Research” published by Springer in 2020.
Helen Byomire Ndagije, a pharmacist and clinical epidemiologist is the Director of Product Safety at the National Drug Authority in Uganda. She is the President of the Africa Chapter of the International Society of Pharmacovigilance (ISoP), holds a masters in business administration and a doctorate in public health. She is known for having introduced a decentralised system of pharmacovigilance in Uganda. She has also been the Vice Chairperson of the African Vaccine Regulator’s Forum(AVAREF) , a network that has recently seen the regulatory system for clinical trials of medicines and vaccines uplifted in the region. She is a member of the Patient Engagement Special interest group of ISoP. She gives pharmacovigilance lectures to undergraduate, masters and post-graduate students and supervises doctorate students in pharmacovigilance.
Global leader in medication safety, currently president of the International Society of Pharmacovigilance (ISoP), an institution with presence in 100 countries, whose mission is to improve the medication safety worldly.
Pharmacist, Epidemiologist, Ms Pharmaceutical Care, MSc Education. With 20 years of experience, she is an international consultant and lecturer in pharmacovigilance, safe use of medications and medical devices, patient safety, patient education, leadership and communication. Member of Research Ethics Committees, she was president of the Colombian Pharmacovigilance Association for 5 years, founding member and Co-chair of the ISoP Special Interest Group (SIG) “Medication errors”. ISoP SIG Risk Communication and SIG Patient Engagement member. Founding member of Latin American Network of Human Factors and Ergonomics in Healthcare Systems (RELAESA). Currently Pharmacy Career Director in Pontificia Universidad Javeriana.
Jo Barnes is Professor in Herbal Medicines and Deputy Head of the School of Pharmacy in the Faculty for Medical and Health Sciences at the University of Auckland in New Zealand. Jo is the chapter lead for the Western Pacific chapter of the International Society of Pharmacovigilance, and was the founding chair of the Herbal and Traditional Medicines special interest of ISoP (2017-2022). Jo was a member of the Executive Committee of ISoP (2006-2009).